2012 focused update of the ESC Guidelines for the management of atrial fibrillation

被引：1786

作者：

Camm, A. John ^{[1
]}

Lip, Gregory Y. H. ^{[1
]}

De Caterina, Raffaele ^{[1
]}

Savelieva, Irene ^{[1
]}

Atar, Dan ^{[1
]}

Hohnloser, Stefan H. ^{[1
]}

Hindricks, Gerhard ^{[1
]}

Kirchhof, Paulus ^{[1
]}

Bax, Jeroen J. ^{[1
]}

Baumgartner, Helmut ^{[1
]}

Ceconi, Claudio ^{[1
]}

Dean, Veronica ^{[1
]}

Deaton, Christi ^{[1
]}

Fagard, Robert ^{[1
]}

Funck-Brentano, Christian ^{[1
]}

Hasdai, David ^{[1
]}

Hoes, Arno ^{[1
]}

Knuuti, Juhani ^{[1
]}

Kolh, Philippe ^{[1
]}

McDonagh, Theresa ^{[1
]}

Moulin, Cyril ^{[1
]}

Popescu, Bogdan A. ^{[1
]}

Reiner, Zeljko ^{[1
]}

Sechtem, Udo ^{[1
]}

Sirnes, Per Anton ^{[1
]}

Tendera, Michal ^{[1
]}

Torbicki, Adam ^{[1
]}

Vahanian, Alec ^{[1
]}

Windecker, Stephan ^{[1
]}

Vardas, Panos ^{[1
]}

Al-Attar, Nawwar ^{[1
]}

Alfieri, Ottavio ^{[1
]}

Angelini, Annalisa ^{[1
]}

Blomstrom-Lundqvist, Carina ^{[1
]}

Colonna, Paolo ^{[1
]}

De Sutter, Johan ^{[1
]}

Ernst, Sabine ^{[1
]}

Goette, Andreas ^{[1
]}

Gorenek, Bulent ^{[1
]}

Hatala, Robert ^{[1
]}

Heidbuchel, Hein ^{[1
]}

Heldal, Magnus ^{[1
]}

Kristensen, Steen Dalby ^{[1
]}

Le Heuzey, Jean-Yves ^{[1
]}

Mavrakis, Hercules ^{[1
]}

Mont, Lluis ^{[1
]}

Filardi, Pasquale Perrone ^{[1
]}

Ponikowski, Piotr ^{[1
]}

Prendergast, Bernard ^{[1
]}

Rutten, Frans H. ^{[1
]}

机构：

[1] St Georges Univ London, Div Clin Sci, Cranmer Terrace, London SW17 0RE, England

来源：

EUROPEAN HEART JOURNAL | 2012年 / 33卷 / 21期

关键词：

Atrial fibrillation; European Society of Cardiology; Guidelines; Anticoagulation; Novel oral anticoagulants; Left atrial appendage occlusion; Rate control; Cardioversion; Rhythm control; Antiarrhythmic drugs; Upstream therapy; Pulmonary vein isolation; Left atrial ablation; Focused update; NET CLINICAL BENEFIT; STROKE RISK STRATIFICATION; HEART RHYTHM ASSOCIATION; RADIOFREQUENCY CATHETER ABLATION; ANTIARRHYTHMIC-DRUG THERAPY; ORAL ANTICOAGULANT DRUGS; NORMALIZED RATIO CONTROL; CARDIOLOGY WORKING GROUP; VEIN ANTRAL ISOLATION; BLEEDING RISK;

D O I：

10.1093/eurheartj/ehs253

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2719 / 2747

页数：29

共 192 条

[1] Abu-Assi E, INT J CARDIOL
[2] Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation - A randomized trial
Ahmed, Sheba
Rienstra, Michiel
Crijns, Harry J. G. M.
Links, Thera P.
Wiesfeld, Ans C. P.
Hillege, Hans L.
Bosker, Hans A.
Lok, Dirk J. A.
Van Veldhuisen, Dirk J.
Van Gelder, Isabelle C.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (15): : 1784 - 1792
[3] New oral anticoagulant drugs in cardiovascular disease
Ahrens, Ingo
Lip, Gregory Y. H.
Peter, Karlheinz
[J]. THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) : 49 - 60
[4] Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
Alexander, John H.
Lopes, Renato D.
James, Stefan
Kilaru, Rakhi
He, Yaohua
Mohan, Puneet
Bhatt, Deepak L.
Goodman, Shaun
Verheugt, Freek W.
Flather, Marcus
Huber, Kurt
Liaw, Danny
Husted, Steen E.
Lopez-Sendon, Jose
De Caterina, Raffaele
Jansky, Petr
Darius, Harald
Vinereanu, Dragos
Cornel, Jan H.
Cools, Frank
Atar, Dan
Luis Leiva-Pons, Jose
Keltai, Matyas
Ogawa, Hisao
Pais, Prem
Parkhomenko, Alexander
Ruzyllo, Witold
Diaz, Rafael
White, Harvey
Ruda, Mikhail
Geraldes, Margarida
Lawrence, Jack
Harrington, Robert A.
Wallentin, Lars
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) : 699 - 708
[5] Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation
Apostolakis, Stavros
Lane, Deirdre A.
Guo, Yutao
Buller, Harry
Lip, Gregory Y. H.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (09) : 861 - 867
[6] ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association
Arbelo, Elena
Brugada, Josep
Hindricks, Gerhard
Maggioni, Aldo
Tavazzi, Luigi
Vardas, Panos
Anselme, Frederic
Inama, Giuseppe
Jais, Pierre
Kalarus, Zbigniew
Kautzner, Josef
Lewalter, Thorsten
Mairesse, Georges
Perez-Villacastin, Julian
Riahi, Sam
Taborsky, Milos
Theodorakis, George
Trines, Serge
[J]. EUROPACE, 2012, 14 (08): : 1094 - 1103
[7] Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients
Arya, Arash
Hindricks, Gerhard
Sommer, Philipp
Huo, Yan
Bollmann, Andreas
Gaspar, Thomas
Bode, Kerstin
Husser, Daniela
Kottkamp, Hans
Piorkowski, Christopher
[J]. EUROPACE, 2010, 12 (02): : 173 - 180
[8] Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study
Banerjee, Amitava
Lane, Deirdre A.
Torp-Pedersen, Christian
Lip, Gregory Y. H.
[J]. THROMBOSIS AND HAEMOSTASIS, 2012, 107 (03) : 584 - 589
[9] Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project
Banerjee, Amitava
Taillandier, Sophie
Olesen, Jonas Bjerring
Lane, Deirdre A.
Lallemand, Benedicte
Lip, Gregory Y. H.
Fauchier, Laurent
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (03) : 295 - 301
[10] Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
Barrett, Yu Chen
Wang, Zhaoqing
Frost, Charles
Shenker, Andrew
[J]. THROMBOSIS AND HAEMOSTASIS, 2010, 104 (06) : 1263 - 1271

← 1 2 3 4 5 6 7 8 9 10 →